Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
House Foods Group is a prominent Japanese conglomerate primarily known for its leadership in the food and beverage industry, particularly in curry and spices. However, the company has a significant presence in the health and life sciences sector through its Health Science business segment and subsidiary, House Wellness Foods. The group focuses on the research and development of functional ingredients, such as curcumin and heat-killed lactic acid bacteria (HK L-137), to create health-promoting beverages and supplements. Their R&D efforts bridge the gap between nutrition and preventative medicine, targeting areas like immune health, liver function, and metabolic support. The company utilizes advanced fermentation and extraction technologies to produce high-quality nutraceuticals for the global market. House Foods Group is publicly traded on the Tokyo Stock Exchange and continues to expand its wellness portfolio to address the needs of an aging population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on House Foods Group.